Breast cancer (BC) is a heterogeneous disease that is classified into three subtypes that guide treatment: hormone receptor-positive, human epidermal growth factor receptor 2 positive (HER2+), and triple-negative. This evidence concerns the gene ERBB2 and breast cancer.